U.S. markets closed

Therapeutic Solutions International, Inc. (TSOI)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0640+0.0030 (+4.92%)
At close: 3:59PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/8/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
143.64M14.17M14.11M12.59M2.06M
Enterprise Value 3
144.43M14.92M15.13M13.54M2.57M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
2.28k224.92223.36354.9677.61
Price/Book (mrq)
N/AN/AN/AN/AN/A
Enterprise Value/Revenue 3
2.30k838.331.33k966.05131.65
Enterprise Value/EBITDA 7
-76.40-20.09-33.57-17.1027.06

Trading Information

Stock Price History

Beta (5Y Monthly) 0.99
52-Week Change 32,361.54%
S&P500 52-Week Change 344.45%
52 Week High 30.1729
52 Week Low 30.0010
50-Day Moving Average 30.0660
200-Day Moving Average 30.0425

Share Statistics

Avg Vol (3 month) 310.51M
Avg Vol (10 day) 37.34M
Shares Outstanding 52.24B
Implied Shares Outstanding 6N/A
Float 1.17B
% Held by Insiders 143.42%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,950.78%

Management Effectiveness

Return on Assets (ttm)-252.82%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)62.68k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)269.00%
Gross Profit (ttm)49.89k
EBITDA -1.84M
Net Income Avi to Common (ttm)-2.2M
Diluted EPS (ttm)-0.0010
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)252.15k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.04M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.15
Book Value Per Share (mrq)-0.00

Cash Flow Statement

Operating Cash Flow (ttm)-663.08k
Levered Free Cash Flow (ttm)62.96k